FRM 2019 Conference Chairs
David F. Albertini
- The forgotten male in infertility practice
- Preimplantation genetic testing for aneuploidy (PGT-A)
- Early stages of embryo development and “artificial” embryos
- IVF risks
- Recognize state-of the-arts developments in reproductive biology and their translational potential for clinical practice in reproductive endocrinology and infertility
- Identify paradigm changes in clinical reproductive medicine, driven by new discoveries in reproductive biology
- Evaluate current popular infertility treatments in selected patient populations
- Apply individualized infertility medicine based on age and functional ovarian reserve of female patients
- Discuss the progress in male infertility
Who Should Attend?
This conference offers to clinicians, basic scientists and trainees in a single lecture hall over two-and-a-half days a comprehensive and very contemporary update on reproductive biology and reproductive clinical endocrinology/infertility. It also presents unique opportunities for interaction between basic scientists and clinicians, with the ultimate goal of the conference being to enhance the quick translation of new developments in reproductive biology to clinical practice in reproductive endocrinology/infertility.
Registrants from 42 countries again offered glowing evaluations for last year’s Foundation for Reproductive Medicine Conference (FRMC).